Veeva Systems today announced that Eli Lilly and Company (Lilly) has committed to Veeva Vault CRM globally. Vault CRM is part of the Vault CRM Suite of applic...

The next phase of competition in the HIV market will be defined not only by achieving viral suppression, but by improving treatment adherence, reducing medicatio...

Callavid intravaginal drug delivery platform selected to advance targeted UTI treatment as part of new programme addressing antibiotic-driven antimicrobial resis...

Accreditation strengthens ECI's ability to provide trusted laboratory testing and integrated support to life sciences organisations ECI announced today th...

Now commercially available, the medium cut-off dialyzer expands access to enhanced middle molecule removal through e...

·        Extension of the INDUCE-seq platform to support adenine base editing (ABE) workflows ·    ...

Tempus joins as a second commercial laboratory partnership to support oncology-focused access within CellCarta's CDx Accelerator Model. CellCarta, a globa...

Milestone marks Kupando's evolution from a research-focused organisation to a clinical-stage biopharmaceutical company Phase 1 trial evaluates KUP101, a diff...

FLASH program, in collaboration with GE HealthCare, to support development of faster, distributed DNA manufacturing for next-generation therapies DNA Scri...

IMCD Group, a leading global partner for the distribution and formulation of speciality chemicals and ingredients, has appointed Vlad Miller as President for the...